Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|June 9, 2020
A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibitionM Eugenia Dieterle, Denise Haslwanter, Robert H Bortz, et al.Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.Cell|August 20, 2021
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitopeArthur S Kim, Natasha M Kafai, Emma S Winkler, et al.Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Powassan Virus Seroprevalence in a U.S. Servicemember Population at High Risk for Tick ExposureAlexandra L Tse, Zoey Dipasqua, Joelle El Hamouche, et al.Cell|June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverJ Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.Nature|November 23, 2018
Protocadherin-1 is essential for cell entry by New World hantavirusesRohit K Jangra, Andrew S Herbert, Rong Li, et al.Mbio|October 5, 2021
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, M Eugenia Dieterle, Anna Z Wec, et al.Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.Plos Computational Biology|January 18, 2022
Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomesGorka Lasso, Saad Khan, Stephanie A Allen, et al.Pageof 9